US EditionOmada Health prices IPO at $19 per share, in middle of expected range
- Omada Health, a 14-year-old chronic care company, priced its IPO at $19 per share and closed its first day at $23 on Nasdaq under ticker OMDA.
- The IPO followed steady growth fueled by virtual care services for chronic conditions, including diabetes, weight management, and expanded support for GLP-1 patients.
- Omada reported first-quarter 2025 revenues up 57% to $55 million and 2024 revenue growth of 38% reaching $170 million, partly due to an alliance with Amazon.
- The $1.1 billion valuation matches Omada’s previous private value, with major investors like Revelation Partners and Andreessen Horowitz holding significant shares valued using the $23 market price.
- Omada's successful IPO amid market challenges suggests resilience in digital health by combining drug therapies and behavioral support for chronic disease management.
Insights by Ground AI
Does this summary seem wrong?
18 Articles
18 Articles
All
Left
3
Center
7
Right
Diabetes startup Omada Health finally went public after 14 years. Here's who made bank.
Omada Health went public on Friday on the Nasdaq.Vanja Savic/Photo by Vanja SavicOmada Health just became the second digital health company to IPO this year.The chronic care company saw its shares jump Friday morning by over 38% above its initial price.Here's what Omada's major investors' stakes are worth after the public market debut.Omada Health just went public at a $1.1 billion valuation — 14 years after its founding.It's the second digital …
·United States
Read Full Article
Coverage Details
Total News Sources18
Leaning Left3Leaning Right0Center7Last UpdatedBias Distribution70% Center
Bias Distribution
- 70% of the sources are Center
70% Center
L 30%
C 70%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
